Records containing: Ocular Hypertension

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2011-11-24
  ClinicalTrials.gov study NCT00457795
• CLINICAL_TRIALS study record update · 2011-11-24
  Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects
• CLINICAL_TRIALS study record update · 2011-11-03
  A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• CLINICAL_TRIALS study record update · 2011-11-03
  A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• CLINICAL_TRIALS study record update · 2011-10-31
  ClinicalTrials.gov study NCT00539526
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2011-10-27
  ClinicalTrials.gov study NCT00541242
• CLINICAL_TRIALS study record update · 2011-10-27
  ClinicalTrials.gov study NCT00538304
• CLINICAL_TRIALS study record update · 2011-09-26
  ClinicalTrials.gov study NCT00834171
• CLINICAL_TRIALS study record update · 2011-09-21
  ClinicalTrials.gov study NCT00811564
• CLINICAL_TRIALS study record update · 2011-09-13
  A Phase III, Randomized, Active Comparator-Controlled, Twelve-Week, Double-Masked Clinical Trial to Compare the Efficacy and Safety of Preservative-Free MK2452 (0.0015%) and Preservative-Free Timolol Maleate (0.5%) in Patients With Open-Angle Glaucoma and Ocular Hypertension
• CLINICAL_TRIALS study record update · 2011-07-08
  A Randomized, Comparison of the Effects of Ganfort and Duotrav on Intraocular Pressure in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Open Label/Evaluator-blind/Cross-over Study
• CLINICAL_TRIALS study record update · 2011-06-23
  ClinicalTrials.gov study NCT01114893
• CLINICAL_TRIALS study record update · 2011-06-23
  Phase 4 Study Evaluating the Relationship Between Intraocular Pressure and Central Corneal Thickness Using Various Instruments in Ocular Hypertension, Normal-tension Glaucoma, Primary Open Angle Glaucoma, Keratoconus and Normal Eyes.
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00332059
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00300443
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00332345
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00332436
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00332540
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00168363
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00332384
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00332072
• CLINICAL_TRIALS study record update · 2011-05-27
  Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma
• CLINICAL_TRIALS study record update · 2011-03-25
  A 6-month, Randomized, Double-masked Comparison of Latanoprost (PhXA41) With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension. A Multi-centre Study in the United States.
• CLINICAL_TRIALS study record update · 2011-03-18
  Central Corneal Thickness After Overnight IOP Monitoring With SENSIMED Triggerfish
• CLINICAL_TRIALS study record update · 2011-03-08
  A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension